Standard Biotools (LAB) Share-based Compensation Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 7.56% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | -24.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.61% |
| Mar 31, 2026 | 10,771.74% |
| Dec 31, 2025 | -16.72% |
| Sep 30, 2025 | 62.10% |
| Jun 30, 2025 | 57.54% |
| Mar 31, 2025 | 170.59% |
| Dec 31, 2024 | 160.83% |
| Sep 30, 2024 | 37.30% |
| Jun 30, 2024 | 9.51% |
| Mar 31, 2024 | -99.46% |
| Dec 31, 2023 | -665.68% |
| Sep 30, 2023 | -24.66% |
| Jun 30, 2023 | 178.58% |
| Mar 31, 2023 | -22.12% |
| Sep 30, 2022 | 165.13% |
| Jun 30, 2022 | -355.35% |
| Mar 31, 2022 | 669.90% |
| Sep 30, 2021 | 1,256.00% |
| Jun 30, 2021 | 1,237.93% |
| Mar 31, 2021 | 259.59% |